Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × cabozantinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 66 Carcinoma, Hepatocellular 23 Prostatic Neoplasms 18 Neoplasm Metastasis 16 Neoplasms 15 Kidney Neoplasms 13 Carcinoma, Non-Small-Cell Lung 13 Neuroendocrine Tumors 8 Carcinoma, Medullary 8 Melanoma 7 Carcinoma, Transitional Cell 7 Brain Neoplasms 7 Urinary Bladder Neoplasms 6 Sarcoma 6 Osteosarcoma 6 Colorectal Neoplasms 6 Breast Neoplasms 6 Thyroid Neoplasms 5 Sarcoma, Ewing 5 Pancreatic Neoplasms 5 Clear-cell metastatic renal cell carcinoma 5 Carcinoma 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Urethral Neoplasms 3 Small Cell Lung Carcinoma 3 Lung Neoplasms 3 Liver Neoplasms 3

Interventions

Geriatric Assessment 9 Standard of Care 3 Preoperative Exercise 3 Observation 2 Nutritional Support 2 Exercise 2 peflavit 1 microcrystalline cellulose 1 fisetin 1 epigallocatechin gallate 1 diacetamate 1 cabozantinib 1 Ultrasonography 1 Tretinoin 1 Therapeutics 1 Temozolomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Spectroscopy, Near-Infrared 1 Restraint, Physical 1 Quercetin 1 Qigong 1 Psychosocial Intervention 1 Protons 1 Photons 1 Nutrition Assessment 1 Methods 1 Immunonutrition Diet 1 Flavonoids 1 Enhanced Recovery After Surgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04134390 2024-01-09

CABOMAYOR

Spanish Oncology Genito-Urinary Group

Phase 2 Completed

Frailty, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡